RecruitingPhase 2NCT07128641

Odronextamab in Low Tumor Volume Advanced FL

Studying Follicular lymphoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Gottfried von Keudell, MD PhD
Principal Investigator
Gottfried Von Keudell, MD, PhD
Beth Israel Deaconess Medical Center
Intervention
Odronextamab(biological)
Enrollment
35 target
Eligibility
18 years · All sexes
Timeline
2025 – 2028

Study locations (1)

Collaborators

Regeneron Pharmaceuticals

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07128641 on ClinicalTrials.gov

Other trials for Follicular lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Follicular lymphoma →

← Back to all trials